An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.
(Q34881233)
scientific article
scientific article
Language:
other details
description | scientific article |
External Links
(P356) |
10.1097/JCP.0B013E31818A6CEA
|
(P698) |
19011431
|
(P8608) |
release_53hr7b34o5dexdnk7o2buwm24q
|